Open access · CC-BY
via OpenAlex
Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson’s disease
Zhidong Zhou, Thevapriya Selvaratnam, Ji Chao Tristan Lee, Yinxia Chao, Eng‐King Tan
Translational Neurodegeneration · 2019 · ▲ 33 citations
Abstract
Parkinson's disease (PD) is the most common neurodegenerative movement disorder, which is characterized by the progressive loss of dopaminergic neurons in the Substantia Nigra pars compacta concomitant with Lewy body formation in affected brain areas. The detailed pathogenic mechanisms underlying the selective loss of dopaminergic neurons in PD are unclear, and no drugs or treatments have been developed to alleviate progressive dopaminergic neuron degeneration in PD. However, the formation of α-synuclein-positive protein aggregates in Lewy body has been identified as a common pathological feature of PD, possibly stemming from the consequence of protein misfolding and dysfunctional proteostasis(definition). Proteostasis is the mechanism for maintaining protein homeostasis via modulation of protein translation, enhancement of chaperone capacity and the prompt clearance of misfolded protein by the ubiquitin proteasome system and autophagy(definition). Deregulated protein translation and impaired capacities of chaperone or protein degradation can disturb proteostasis processes, leading to pathological protein aggregation and neurodegeneration in PD. In recent years, multiple molecular targets in the modulation of protein translation vital to proteostasis and dopaminergic neuron degeneration have been identified. The potential pathophysiological and therapeutic significance of these molecular targets to neurodegeneration in PD is highlighted.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s40035-019-0145-0
- Canonical
- link ↗
- Fetched
- 2026-11-05 MST
Cite this
APA
Zhou, Z., Selvaratnam, T., Lee, J.C.T., Chao, Y., & Tan, E. (2019). Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson’s disease. <em>Translational Neurodegeneration</em>. https://doi.org/10.1186/s40035-019-0145-0
Vancouver
Zhou Z, Selvaratnam T, Lee JCT, Chao Y, Tan E. Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson’s disease. Translational Neurodegeneration. 2019. doi:10.1186/s40035-019-0145-0.
BibTeX
@article{zhidong2019Molecu,
title = {Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson’s disease},
author = {Zhidong Zhou and Thevapriya Selvaratnam and Ji Chao Tristan Lee and Yinxia Chao and Eng‐King Tan},
journal = {Translational Neurodegeneration},
year = {2019},
doi = {10.1186/s40035-019-0145-0},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Neurochemistry 2025
Open access · CC-BY
Clearance Pathways for α‐Synuclein in Parkinson's Disease
Acta Neuropathologica Communications 2014
Open access · CC-BY
Models of α-synuclein aggregation in Parkinson’s disease
Molecular Neurodegeneration 2020
Open access · CC-BY
Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway
Aging Cell 2022
Open access · CC-BY
Loss of miR‐34 in Drosophila dysregulates protein translation and protein turnover in the aging brain
Acta Medica 2021
Open access · CC-BY
An Overview of Alpha Synuclein Protein and Its Role in Parkinson’s disease
Molecular Psychiatry 2019
Citation only